Traws Pharma, Inc. — Director's Dealing 2020

Jul 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2020-07-09

Reporting Person: Guerin Mark Patrick (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-09	Stock Appreciation Right	$0.56	A	543000	Acquired	2030-07-09	Common Stock (543000)	Direct

Footnotes

F1: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.